The biopharma company achieved $1 billion in revenue for the first time in its September-ended quarter. More recently, it achieved a more significant milestone when it turned prof ...

A special CBI court in Ahmedabad on Thursday sentenced a former employee of United India Insurance and two others to five years rigorous imprisonment for claiming insurance through fraudulent means, ...

Krystal Biotech (KRYS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Discover why NNNN's pivot to oncology and other assays faces challenges as COVID-related revenues decline, with valuation ...

Trump’s tariffs and the trade war continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.

MAIA’s Chairman and CEO Vlad Vitoc, M.D., expressed optimism regarding the results, stating, "This new benchmark of 17.8 months median OS is nearly triple the recognized SOC data for third-line NSCLC ...

The agreement was signed during the state visit of Paraguayan President Santiago Peña Palacios to India from June 2-4, 2025.

Boosted by strong demand, Rhythm Pharmaceuticals joins the ranks of biotech stocks to watch looking to engineer a breakout.

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for drug and agricultural development.

Later this month, the Food and Drug Administration is widely expected to approve a groundbreaking twice-yearly injection to ...

Abeona's ZEVASKYN approval and a $3.1 million price point are undervalued by the market. Find out why ABEO stock is a Buy.

Any point can be considered low -- even after massive gains -- provided there is plenty of upside left. That brings us to ...